Immunoprotective effect of Cu/Zn superoxide dismutase on myeloid graffi tumor-bearing hamsters

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 55, Issue 7-8, 2000, Pages 649-656

  Toshkova, Reneta A ^a   Dimitrova, Petia A ^a   Ivanova, Emilia H ^a   Dolashka, Pavlina A ^a   Angelova, Maria B ^a   Pashova, Svetlana B ^a   Slokoska, Ludmila S ^a   Voelter, Wolfgang ^b  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Humicola lutea; Immunotherapy; Superoxide Dismutase; Tumors

Indexed keywords

B LYMPHOCYTE; CANCER TRANSPLANTATION; DISEASE MODEL; HAMSTER; HUMICOLA LUTEA; MORTALITY; MYELOID TUMOR; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; SUPEROXIDE DISMUTASE; SURVIVAL; T LYMPHOCYTE; TRANSPLANTATION; TUMOR CELL;

ANIMALIA; CRICETINAE; HUMICOLA LUTEA;

EID: 0033836137     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2000-7-826     Document Type: Article

References (37)

1. Alexandoff A. B., Robins A. R., Murray A. and James K. (1998), Tumor immunology: false hopes - new Horizonts?, Immunol. Today 19, 247-250.
2. Ambrosone C. B., Freudenheim J. L., Thompson P. A., Bowman E., Vena J. E., Marshall J. R., Graham S., Laughlin R., Nemoto T. and Shields P.G. (1999), Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59, 602-606.
3. Arivazhagan S., Kavitha K. and Nagini S. (1997), Erytrocyte lipid peroxidation and antioxidants in gastric cancer patients. Cell. Biochem. Funct. 15, 15-18.
4. Beauchamp C. and Fridovich I. (1971), Superoxide dismutase: Improved assays and an assay applicable to polyacrilamide gels. Anal. Biochem. 44, 276-287.
5. Bittinger F., Gonzales-Garcia J. L., Klein C. L., Brochhausen C., Offner F. and Kirkpatrick C. J. (1998), Production of superoxide by human malignant melanoma cells. Melanoma Res. 8, 381-387.
6. Davis B. J. (1964), Disc electrophoresis-II. Method and application to human serum proteins. Sann. N. Y. Acad. Sci. 121, 404-427.
7. Dolashka-Angelova P., Angelova M., Genova L., Stoeva S. and Voelter W. (1999), A novel Cu/Zn supcroxide dismutase from the fungal strain Humicola lutea 110: isolation and physico-chemical characterization. Spectrochim. Acta, part A 55, 2249-2260.
8. Finke J., Ferrone S., Frey A., Mufson A. and Ochoa A. (1999), Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol. Today 20, 158-160.
9. Grammatico P., Maresca V., Roccella F., Roccella M., Biondo L., Catricala C. and Picardo M. (1998), Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients. Exp. Dermatol. 7, 205-212.
10. Jakimov M., Mladenov Z., Konstantinov A. and Yanchev I. (1979), Transplantable myeloid tumor in hamsters (MTH) induced by Graffi virus. Gen. and Compar. Pathol. 6, 24-35.
11. Janssen A. M., Bosman C. B., Kruidenier L., Griffioen G., Lamers C. B., van Krieken J. H., van de Velde C. J. and Verspaget H. W. (1999), Superoxide dismutases in the human colorectal cancer sequence. J. Cancer Res. Clin. Oncol. 125, 327-335.
12. Jung K., Seidel B., Rudolph B., Lein M., Cronauer M. V, Henke W., Hampel G., Schnorr D. and Loening S. A. (1997), Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med. 23, 127-133.
13. Kahlos K., Pitkanen S., Hassinen I., Linnainmaa K. and Kinnula V. L. (1999), Generation of reactive oxygen species by human mesothelioma cells. Brit. J. Cancer 80, 25-31.
14. Kiningham K. K. and St Clair D. K. (1997), Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res. 57, 5265-5271.
15. Kogawa K., Muramatsu H., Tanaka M., Nishihori Y., Hagiwara S., Kuribayashi K., Nakamura K., Koike K., Sakamaki S. and Niitsu Y. (1999), Enhanced inhibition of experimental metastasis by the combination chemotherapy Cu/ZnSOD and adriamycin. Clin. Exp. Metastasis 17, 239-244.
16. Leu W. R., Eddeston W. F., Hadden J. W. and Good R. A. (1972), Mechanism of action of migration inhibitory factor (MIF). Evidence for a receptor for MIF present on the peritoneal macrophages but not on alveolar macrophages. J. Exp. Med. 136, 589-603.
17. Li J. J., Rhim J. S., Schlegel R., Vousden K. H. and Colburn N. H. (1998), Expression of dominant negative Jun inhibits elevated AP-1 and NF-kB transactivation and supresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene 16, 2711-2721.
18. Liaw K. Y., Lee P. H., Wu F. C., Tsai J. S. and Lin-Shiau S. Y. (1997), Zinc, copper and superoxide dismutase in hepatocellular carcinoma. Amer. J. Gastroenterol. 92, 2260-2263.
19. Lowry O. H., Rosenbrough H. J., Faar A. L. and Randall R. J. (1951), Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
20. Lu Y. P., Lou Y. R., Yen P., Newmark H. L., Mirochnitchenko O. I., Inouye M. and Huang M. T. (1997), Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res. 57, 1468-1474.
21. Mason P. R. and Gvvanzura L. (1990), Reduced lymphocyte responses to mitogens in natural and experimental trichomoniasis Infect. Immun. 58, 3553-3557.
22. Misra H. P. and Fridovich I. (1977), Superoxide dismutase and peroxidase: a positive activity strain applicable to polyacrylamide gel electropherograms. J. Biol. Chem. 252, 6421-6423.
23. Oberley L. W. and Buettner G. R. (1979), Role of superoxide dismutase in cancer: A rewiew. Cancer Res. 39, 1141-1149.
24. Oberley T. D. and Oberley L. W. (1997), Antioxidant enzyme levels in cancer. Histol. and Histopathol. 12, 525-535.
25. Okada F., Nakai K., Kobayashi T., Shibata T., Tagami S., Kawakami Y., Kitazawa T., Kominami R., Yoshimura S., Suzuki K., Tanigushi N., Inanami O., Kuwabara M., Kishida H., Nakae D., Konishi Y., Moriuchi T. and Hosokawa M. (1999), Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells. Br. J. Cancer 79, 377-385.
26. Osada Y., Mitsuyama M. Une T., Matsumoto K., Otani T., Satoh M., Ogawa H. and Nomoto K. (1982), Effect of L18 MDP(Ala), a synthetic derivate of muramyldipeptide on nonspecific resistance of mice to microbial infections. Infect. Immun. 37, 292-300.
27. Palazzotti B., Pani G., Colavitti R., De Leo M. E., Bedogni B., Borrello S. and Galeotti T. (1999), Increased growth capacity of cervical-carcinoma cells overexpressing manganous superoxide-dismutase. Int. J. Cancer 82, 145-150.
28. Pappenheim A. (1911), Grundiss der hamatologischen Diagnostik. Leipzig.
29. Pashova S., Slokoska L., Dolashka-Angelova P., Vassilev S., Sheremetska P. and Angelova M. (1999), Effect of dissolved oxygen concentration on superoxide dismutase production by Humicola lutea cells. Z. Naturforsch. 54c, 1049-1054.
30. Seidman M. D., Quirk W. S. and Shirwany N. A. (1999), Reactive oxygen metabolites, antioxidants and head and neck cancer. Head Neck 21, 467-479.
31. Siemankowski L. M., Morreale J. and Briehl M. M. (1999), Antioxidant defenses in the TNF-treated MGF-7 cells: selective increase in MnSOD. Free Rad. Biol. Med. 26, 919-924.
32. Sies H. (1993). Strategies of antioxidant defense. Eur. J. Biochem. 215, 213-219.
33. Tanaka M., Kogawa K., Nishihori Y., Kuribayashi K., Nakamura K., Muramatsu H., Koike K., Sakamaki S. and Niitsu Y. (1997), Suppression of intracellular Cu-ZnSOD results in enhanced motility and metastasis of Meth A sarcoma cells. Int. J. Cancer 73, 187-192.
34. Toshkova R. (1995), Attemps for immunomodulation in hamsters with transplanted myeloid tumor, previously induced by Graffi virus. PhD Dissertation, Sofia.
35. Vulchanov A. (1954), To the method of examination of the phagocytic activity of blood., Izvest. Biol. Inst. 5, 411-413 (in Bulg.).
36. Weber G. F. and Bruch H. P. (1992), The pharmacology of superoxide dismutase. Pharmazie 47, 159-167.
37. Zhong W., Oberley L. W., Oberley T. D. and St Clair D. K. (1997), Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14, 481-490.